Bio-Rad Laboratories, Inc. (BIO)
USD 323.94
(-4.12%)
USD 323.94
(-4.12%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 2.67 Billion USD | -4.67% |
| 2022 | 2.8 Billion USD | -4.12% |
| 2021 | 2.92 Billion USD | 14.81% |
| 2020 | 2.54 Billion USD | 10.12% |
| 2019 | 2.31 Billion USD | 0.94% |
| 2018 | 2.29 Billion USD | 6.02% |
| 2017 | 2.16 Billion USD | 4.45% |
| 2016 | 2.06 Billion USD | 2.41% |
| 2015 | 2.01 Billion USD | -7.15% |
| 2014 | 2.17 Billion USD | 1.99% |
| 2013 | 2.13 Billion USD | 3.07% |
| 2012 | 2.06 Billion USD | -0.21% |
| 2011 | 2.07 Billion USD | 7.6% |
| 2010 | 1.92 Billion USD | 8.01% |
| 2009 | 1.78 Billion USD | 1.13% |
| 2008 | 1.76 Billion USD | 20.76% |
| 2007 | 1.46 Billion USD | 14.69% |
| 2006 | 1.27 Billion USD | 7.87% |
| 2005 | 1.18 Billion USD | 8.35% |
| 2004 | 1.09 Billion USD | 8.63% |
| 2003 | 1 Billion USD | 12.4% |
| 2002 | 892.72 Million USD | 9.2% |
| 2001 | 817.5 Million USD | 12.62% |
| 2000 | 725.88 Million USD | 32.1% |
| 1999 | 549.5 Million USD | 24.35% |
| 1998 | 441.9 Million USD | 3.51% |
| 1997 | 426.9 Million USD | 1.93% |
| 1996 | 418.8 Million USD | 5.6% |
| 1995 | 396.6 Million USD | 11.62% |
| 1994 | 355.3 Million USD | 8.13% |
| 1993 | 328.6 Million USD | -0.51% |
| 1992 | 330.3 Million USD | 6.31% |
| 1991 | 310.7 Million USD | 8.37% |
| 1990 | 286.7 Million USD | 21.33% |
| 1989 | 236.3 Million USD | 18.8% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 610.82 Million USD | -10.33% |
| 2024 Q3 | 649.72 Million USD | 1.76% |
| 2024 Q2 | 638.47 Million USD | 4.53% |
| 2023 Q3 | 632.12 Million USD | -7.19% |
| 2023 Q2 | 681.11 Million USD | 0.63% |
| 2023 FY | 2.67 Billion USD | -4.67% |
| 2023 Q4 | 681.18 Million USD | 7.76% |
| 2023 Q1 | 676.84 Million USD | -7.32% |
| 2022 Q2 | 691.09 Million USD | -1.28% |
| 2022 Q1 | 700.06 Million USD | -4.46% |
| 2022 FY | 2.8 Billion USD | -4.12% |
| 2022 Q4 | 730.28 Million USD | 7.27% |
| 2022 Q3 | 680.8 Million USD | -1.49% |
| 2021 FY | 2.92 Billion USD | 14.81% |
| 2021 Q1 | 726.79 Million USD | -7.98% |
| 2021 Q2 | 715.93 Million USD | -1.49% |
| 2021 Q3 | 747.04 Million USD | 4.35% |
| 2021 Q4 | 732.76 Million USD | -1.91% |
| 2020 Q4 | 789.83 Million USD | 22.03% |
| 2020 Q3 | 647.26 Million USD | 20.56% |
| 2020 Q2 | 536.88 Million USD | -6.08% |
| 2020 Q1 | 571.64 Million USD | -8.45% |
| 2020 FY | 2.54 Billion USD | 10.12% |
| 2019 Q2 | 572.61 Million USD | 3.36% |
| 2019 Q4 | 624.42 Million USD | 11.38% |
| 2019 Q1 | 553.97 Million USD | -10.29% |
| 2019 Q3 | 560.63 Million USD | -2.09% |
| 2019 FY | 2.31 Billion USD | 0.94% |
| 2018 Q3 | 545.13 Million USD | -5.34% |
| 2018 Q4 | 617.54 Million USD | 13.28% |
| 2018 FY | 2.29 Billion USD | 6.02% |
| 2018 Q1 | 551.51 Million USD | -11.11% |
| 2018 Q2 | 575.91 Million USD | 4.42% |
| 2017 Q3 | 535 Million USD | 6.01% |
| 2017 Q4 | 620.43 Million USD | 15.97% |
| 2017 Q1 | 500.05 Million USD | -12.49% |
| 2017 FY | 2.16 Billion USD | 4.45% |
| 2017 Q2 | 504.66 Million USD | 0.92% |
| 2016 Q4 | 571.45 Million USD | 12.33% |
| 2016 FY | 2.06 Billion USD | 2.41% |
| 2016 Q2 | 516.77 Million USD | 9.67% |
| 2016 Q1 | 471.19 Million USD | -17.41% |
| 2016 Q3 | 508.74 Million USD | -1.55% |
| 2015 FY | 2.01 Billion USD | -7.15% |
| 2015 Q2 | 506.1 Million USD | 7.04% |
| 2015 Q3 | 469.96 Million USD | -7.14% |
| 2015 Q4 | 570.55 Million USD | 21.41% |
| 2015 Q1 | 472.82 Million USD | -20.96% |
| 2014 FY | 2.17 Billion USD | 1.99% |
| 2014 Q4 | 598.22 Million USD | 12.74% |
| 2014 Q2 | 536.83 Million USD | 5.4% |
| 2014 Q1 | 509.34 Million USD | -15.48% |
| 2014 Q3 | 530.64 Million USD | -1.15% |
| 2013 Q1 | 499.67 Million USD | -12.92% |
| 2013 Q2 | 525.32 Million USD | 5.13% |
| 2013 Q3 | 505.06 Million USD | -3.86% |
| 2013 FY | 2.13 Billion USD | 3.07% |
| 2013 Q4 | 602.63 Million USD | 19.32% |
| 2012 FY | 2.06 Billion USD | -0.21% |
| 2012 Q2 | 510.42 Million USD | 4.97% |
| 2012 Q1 | 486.27 Million USD | -11.62% |
| 2012 Q4 | 573.83 Million USD | 15.07% |
| 2012 Q3 | 498.69 Million USD | -2.3% |
| 2011 FY | 2.07 Billion USD | 7.6% |
| 2011 Q3 | 516.51 Million USD | -0.99% |
| 2011 Q2 | 521.65 Million USD | 7.53% |
| 2011 Q4 | 550.23 Million USD | 6.53% |
| 2011 Q1 | 485.12 Million USD | -9.11% |
| 2010 FY | 1.92 Billion USD | 8.01% |
| 2010 Q2 | 467.66 Million USD | 2.96% |
| 2010 Q1 | 454.23 Million USD | -8.25% |
| 2010 Q3 | 471.5 Million USD | 0.82% |
| 2010 Q4 | 533.72 Million USD | 13.2% |
| 2009 FY | 1.78 Billion USD | 1.13% |
| 2009 Q4 | 495.07 Million USD | 7.38% |
| 2009 Q3 | 461.05 Million USD | 7.93% |
| 2009 Q2 | 427.18 Million USD | 6.55% |
| 2009 Q1 | 400.93 Million USD | -10.5% |
| 2008 Q3 | 441.84 Million USD | -2.33% |
| 2008 FY | 1.76 Billion USD | 20.76% |
| 2008 Q4 | 447.96 Million USD | 1.39% |
| 2008 Q1 | 422.19 Million USD | -8.16% |
| 2008 Q2 | 452.36 Million USD | 7.14% |
| 2007 Q4 | 459.68 Million USD | 35.31% |
| 2007 Q2 | 339.11 Million USD | 5.15% |
| 2007 Q1 | 322.5 Million USD | -6.0% |
| 2007 FY | 1.46 Billion USD | 14.69% |
| 2007 Q3 | 339.74 Million USD | 0.19% |
| 2006 Q4 | 343.08 Million USD | 12.57% |
| 2006 Q3 | 304.76 Million USD | -4.09% |
| 2006 Q2 | 317.74 Million USD | 3.05% |
| 2006 Q1 | 308.33 Million USD | 0.34% |
| 2006 FY | 1.27 Billion USD | 7.87% |
| 2005 FY | 1.18 Billion USD | 8.35% |
| 2005 Q4 | 307.28 Million USD | 8.5% |
| 2005 Q3 | 283.22 Million USD | -2.77% |
| 2005 Q2 | 291.3 Million USD | -2.63% |
| 2005 Q1 | 299.17 Million USD | -2.82% |
| 2004 Q2 | 260.54 Million USD | -2.29% |
| 2004 Q4 | 307.86 Million USD | 18.94% |
| 2004 Q3 | 258.84 Million USD | -0.65% |
| 2004 Q1 | 266.64 Million USD | 0.17% |
| 2004 FY | 1.09 Billion USD | 8.63% |
| 2003 Q4 | 266.2 Million USD | 7.47% |
| 2003 Q3 | 247.7 Million USD | 1.72% |
| 2003 Q2 | 243.5 Million USD | -1.0% |
| 2003 Q1 | 245.96 Million USD | 1.22% |
| 2003 FY | 1 Billion USD | 12.4% |
| 2002 FY | 892.72 Million USD | 9.2% |
| 2002 Q4 | 243 Million USD | 8.06% |
| 2002 Q3 | 224.87 Million USD | 4.76% |
| 2002 Q2 | 214.66 Million USD | 2.13% |
| 2002 Q1 | 210.18 Million USD | -9.94% |
| 2001 FY | 817.5 Million USD | 12.62% |
| 2001 Q4 | 233.38 Million USD | 25.4% |
| 2001 Q1 | 202.66 Million USD | 10.73% |
| 2001 Q3 | 186.1 Million USD | -4.73% |
| 2001 Q2 | 195.35 Million USD | -3.61% |
| 2000 Q1 | 183.68 Million USD | -5.51% |
| 2000 Q4 | 183.02 Million USD | 5.13% |
| 2000 Q3 | 174.08 Million USD | -5.94% |
| 2000 Q2 | 185.08 Million USD | 0.76% |
| 2000 FY | 725.88 Million USD | 32.1% |
| 1999 Q1 | 125.7 Million USD | 5.81% |
| 1999 Q3 | 113.5 Million USD | -1.99% |
| 1999 FY | 549.5 Million USD | 24.35% |
| 1999 Q4 | 194.4 Million USD | 71.28% |
| 1999 Q2 | 115.8 Million USD | -7.88% |
| 1998 Q2 | 107.9 Million USD | -7.14% |
| 1998 FY | 441.9 Million USD | 3.51% |
| 1998 Q4 | 118.8 Million USD | 20.0% |
| 1998 Q1 | 116.2 Million USD | 0.35% |
| 1998 Q3 | 99 Million USD | -8.25% |
| 1997 Q1 | 105.9 Million USD | -7.11% |
| 1997 FY | 426.9 Million USD | 1.93% |
| 1997 Q4 | 115.8 Million USD | 16.38% |
| 1997 Q3 | 99.5 Million USD | -5.95% |
| 1997 Q2 | 105.8 Million USD | -0.09% |
| 1996 Q2 | 100 Million USD | -7.66% |
| 1996 Q1 | 108.3 Million USD | 0.37% |
| 1996 FY | 418.8 Million USD | 5.6% |
| 1996 Q4 | 114 Million USD | 18.01% |
| 1996 Q3 | 96.6 Million USD | -3.4% |
| 1995 Q3 | 92.9 Million USD | -5.11% |
| 1995 Q2 | 97.9 Million USD | 0.0% |
| 1995 FY | 396.6 Million USD | 11.62% |
| 1995 Q1 | 97.9 Million USD | 1.24% |
| 1995 Q4 | 107.9 Million USD | 16.15% |
| 1994 FY | 355.3 Million USD | 8.13% |
| 1994 Q3 | 83.8 Million USD | -1.53% |
| 1994 Q2 | 85.1 Million USD | -5.13% |
| 1994 Q1 | 89.7 Million USD | 2.75% |
| 1994 Q4 | 96.7 Million USD | 15.39% |
| 1993 FY | 328.6 Million USD | -0.51% |
| 1993 Q1 | 80.5 Million USD | -8.63% |
| 1993 Q3 | 78.9 Million USD | -3.55% |
| 1993 Q4 | 87.3 Million USD | 10.65% |
| 1993 Q2 | 81.8 Million USD | 1.61% |
| 1992 FY | 330.3 Million USD | 6.31% |
| 1992 Q4 | 88.1 Million USD | 12.09% |
| 1992 Q3 | 78.6 Million USD | -1.75% |
| 1992 Q2 | 80 Million USD | -4.31% |
| 1992 Q1 | 83.6 Million USD | 1.46% |
| 1991 FY | 310.7 Million USD | 8.37% |
| 1991 Q3 | 75.1 Million USD | -1.83% |
| 1991 Q1 | 76.7 Million USD | -4.48% |
| 1991 Q2 | 76.5 Million USD | -0.26% |
| 1991 Q4 | 82.4 Million USD | 9.72% |
| 1990 Q3 | 69.5 Million USD | 1.02% |
| 1990 FY | 286.7 Million USD | 21.33% |
| 1990 Q1 | 68.1 Million USD | 5.09% |
| 1990 Q4 | 80.3 Million USD | 15.54% |
| 1990 Q2 | 68.8 Million USD | 1.03% |
| 1989 Q1 | 56.3 Million USD | 5.63% |
| 1989 Q2 | 60 Million USD | 6.57% |
| 1989 Q3 | 55.1 Million USD | -8.17% |
| 1989 Q4 | 64.8 Million USD | 17.6% |
| 1989 FY | 236.3 Million USD | 18.8% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Abbott Laboratories | 40.1 Billion USD | 93.34% |
| Allurion Technologies Inc. | 53.46 Million USD | -4896.095% |
| Artivion, Inc. | 354 Million USD | -654.585% |
| Avanos Medical, Inc. | 673.3 Million USD | -296.742% |
| Butterfly Network, Inc. | 65.9 Million USD | -3953.508% |
| Butterfly Network, Inc. | 65.9 Million USD | -3953.508% |
| Boston Scientific Corporation | 14.24 Billion USD | 81.241% |
| Perspective Therapeutics, Inc. | 7.1 Million USD | -37502.224% |
| CONMED Corporation | 1.24 Billion USD | -115.259% |
| Edwards Lifesciences Corporation | 6 Billion USD | 55.515% |
| Paragon 28, Inc. | 216.38 Million USD | -1134.472% |
| Glaukos Corporation | 314.71 Million USD | -748.798% |
| Globus Medical, Inc. | 1.56 Billion USD | -70.309% |
| Inspire Medical Systems, Inc. | 624.79 Million USD | -327.539% |
| Integer Holdings Corporation | 1.59 Billion USD | -67.302% |
| Medtronic plc | 32.36 Billion USD | 91.746% |
| Nevro Corp. | 425.17 Million USD | -528.275% |
| Owlet, Inc. | 54.01 Million USD | -4845.866% |
| Penumbra, Inc. | 1.05 Billion USD | -152.358% |
| Vicarious Surgical Inc. | - USD | -Infinity% |
| Smith & Nephew plc | 5.54 Billion USD | 51.86% |
| Sonendo, Inc. | 43.86 Million USD | -5989.734% |
| STERIS plc | 5.13 Billion USD | 48.017% |
| Stryker Corporation | 20.49 Billion USD | 86.968% |
| Vapotherm, Inc. | 68.66 Million USD | -3790.055% |
| Zimmer Biomet Holdings, Inc. | 7.39 Billion USD | 63.874% |